nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ACCELERATED INFLIXIMAB INFUSION SAFETY AND TOLERABILITY IS NON-INFERIOR TO STANDARD INFUSION PROTOCOL IN INFLAMMATORY BOWEL DISEASE PATIENTS – A RANDOMIZED CONTROLLED STUDY
|
Abushamma, Suha |
|
|
164 |
4S |
p. S11-S12 |
artikel |
2 |
ACONITATE DECARBOXYLASE 1 IS A KEY REGULATOR OF COLITIS
|
McNamara, Kara |
|
|
164 |
4S |
p. S58 |
artikel |
3 |
A DIET AND LIFESTYLE-FACTOR INTERVENTION PROGRAM TO IMPROVE NUTRITIONAL STATUS, SYMPTOMS, AND QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Rogers, Joseph |
|
|
164 |
4S |
p. S20 |
artikel |
4 |
AMINOSALICYLATE USE IN PEDIATRIC PATIENTS WITH CROHN’S DISEASE
|
Patel, Perseus |
|
|
164 |
4S |
p. S41-S42 |
artikel |
5 |
ANALYSIS OF THE GENETIC EXPRESSION OF COLON CANCER GENETIC BIOMARKERS ON INFLAMMATORY BOWEL DISEASE ON BLOOD AND BIOPSY SAMPLES
|
Martinez, Evelyn Calderon |
|
|
164 |
4S |
p. S49 |
artikel |
6 |
AN ASSESSMENT OF HEALTHCARE PROFESSIONAL KNOWLEDGE REGARDING INVESTIGATIONAL STEM CELL THERAPIES FOR PATIENTS WITH CROHN’S PERIANAL FISTULA: A US MULTISPECIALITY EDUCATIONAL NEEDS SURVEY
|
Salinas, Greg |
|
|
164 |
4S |
p. S80 |
artikel |
7 |
A NEW MODEL TO STUDY INTESTINAL FIBROSIS USING IPSC-DERIVED HUMAN EPITHELIAL AND MESENCHYMAL CELLS FROM CROHN’S DISEASE PATIENTS
|
Valencia, Christian Wong |
|
|
164 |
4S |
p. S58 |
artikel |
8 |
AN OBSERVATIONAL STUDY DEMONSTARTING THE MEASUREMENT, CHARACTERIZATION AND VALIDATION OF EXPRESSIONS OF CALPROTECTIN IN HUMAN SWEAT THROUGH A SWEAT WEARABLE
|
Prasad, Shalini |
|
|
164 |
4S |
p. S23 |
artikel |
9 |
A NOVEL BISPECIFIC CD8 TREG MODULATOR TARGETING CYTOLYTIC CD8 REGULATORY T CELLS REDUCES PATHOGENIC CD4 T CELLS AND INFLAMMATION IN TRANSLATIONAL MODELS OF INTESTINAL AUTOIMMUNE AND INFLAMMATORY DISEASE
|
Gardell, Jennifer |
|
|
164 |
4S |
p. S15-S16 |
artikel |
10 |
A NOVEL DRUG THERAPY INDUCES MITOCHONDRIAL BIOGENESIS AND ATTENUATES COLITIS
|
Bhogoju, Sarayu |
|
|
164 |
4S |
p. S70 |
artikel |
11 |
A NOVEL GUT-RESTRICTED ARYL HYDROCARBON RECEPTOR AGONIST WITH ACTIVITY IN THE DEXTRAN SODIUM SULFATE COLITIS MURINE MODEL
|
Davidson, Matt |
|
|
164 |
4S |
p. S4 |
artikel |
12 |
AN UNUSUAL MANIFESTATION OF METASTATIC CROHN’S DISEASE: A CASE REPORT
|
Ashrafinia, Narges |
|
|
164 |
4S |
p. S30 |
artikel |
13 |
A NURSE LED INTERVENTION TO IMPROVE ACCESS TO CARE USING A TELEPHONE TRIAGE ALGORITHM
|
Banty, Andrea |
|
|
164 |
4S |
p. S51 |
artikel |
14 |
A PHASE II OPEN LABEL STUDY OF NEIHULIZUMAB, AN ANTI-CD162 (PSGL-1) ANTIBODY, IN PATIENTS WITH MODERATE TO SEVERE ACTIVE, ANTI-TNFα AND/OR ANTI-INTEGRIN REFRACTORY ULCERATIVE COLITIS
|
Rubin, David |
|
|
164 |
4S |
p. S99-S100 |
artikel |
15 |
A PRECLINICAL MODEL OF STENOTIC CROHN’S DISEASE FOR THE STUDY OF MECHANISMS OF MOTILITY DYSFUNCTION IN IBD
|
Johnson, John |
|
|
164 |
4S |
p. S4-S5 |
artikel |
16 |
A RARE PRESENTATION OF MYCOPHENOLATE MOFETIL-INDUCED SEGMENTAL COLITIS MASQUERADING AS ISCHEMIC COLITIS
|
Miranda, Clive |
|
|
164 |
4S |
p. S1 |
artikel |
17 |
ARTHRITIS AND ARTHRALGIA AS EXTRAINTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB: A META-ANALYSIS
|
dos Anjos, Gabriele Alves |
|
|
164 |
4S |
p. S1-S2 |
artikel |
18 |
ASSESSMENT OF THE IMMUNE CELL LANDSCAPE IN INFLAMMATORY BOWEL DISEASE
|
Martinez, Evelyn Calderon |
|
|
164 |
4S |
p. S50 |
artikel |
19 |
ASSOCIATION BETWEEN ANTIBIOTIC USE AND INFLAMMATORY BOWEL DISEASE OUTCOMES
|
Liu, Luke |
|
|
164 |
4S |
p. S42 |
artikel |
20 |
ASSOCIATION OF CYCLING BETWEEN ANTI-TNFS VERSUS SWITCHING TO USTEKINUMAB WITH MEDICATION PERSISTENCE IN ANTI-TNF EXPERIENCED PATIENTS WITH CROHN'S DISEASE
|
Zhdanava, Maryia |
|
|
164 |
4S |
p. S42-S43 |
artikel |
21 |
AUPHOS, A NOVEL DRUG THAT IMPROVES COLITIS BY MICROBIOME INDUCED METABOLIC CHANGES
|
Warinner, James |
|
|
164 |
4S |
p. S62-S63 |
artikel |
22 |
BULK RNA-SEQUENCING OF BLOOD INFORMS MOLECULAR DIAGNOSES IN VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE
|
Collen, Lauren |
|
|
164 |
4S |
p. S71-S72 |
artikel |
23 |
BUTYRATE AMELIORATES PANETH CELL DEFECTS, TOTAL INFLAMMATION, AND EPITHELIAL CELL APOPTOSIS DURING MITOCHONDRIAL DYSFUNCTION DRIVEN BY PROHIBITIN 1-DEFICIENCY
|
Alula, Kibrom |
|
|
164 |
4S |
p. S63 |
artikel |
24 |
BUTYRATE-INDUCED MITOCHONDRIAL FUNCTION IMPROVES BARRIER FUNCTION IN INFLAMMATORY BOWEL DISEASE (IBD)
|
Conder, Evan |
|
|
164 |
4S |
p. S91 |
artikel |
25 |
CHARACTERIZING THE JOHNS HOPKINS INFLAMMATORY BOWEL DISEASE COHORT USING OMOP CDM
|
Haas, Leonard |
|
|
164 |
4S |
p. S43-S44 |
artikel |
26 |
COLITIS-ASSOCIATED COLON CANCER: EXPLORING THE DCLK1-S-MMP13-P53 AXIS
|
Yusuf, Kafayat |
|
|
164 |
4S |
p. S58-S59 |
artikel |
27 |
COLON TARGETED DELIVERY AND STABILIZATION OF MONOCLONAL ANTIBODIES FOR LOCAL TREATMENT OF INFLAMMATORY BOWEL DISEASES
|
Yadav, Vipul |
|
|
164 |
4S |
p. S5 |
artikel |
28 |
COMMENSAL GUT BACTERIA REGULATE HIF ACTIVITY TO PROMOTE INTESTINAL HOMEOSTASIS
|
Dowdell, Alexander |
|
|
164 |
4S |
p. S63 |
artikel |
29 |
COMPARATIVE EFFECTS OF BIOLOGICS IN PREVENTING PENETRATING COMPLICATIONS IN CROHN’S DISEASE
|
Deepak, Parakkal |
|
|
164 |
4S |
p. S9 |
artikel |
30 |
Cover
|
|
|
|
164 |
4S |
p. OFC |
artikel |
31 |
CREATINE KINASE EXPRESSION IS PROTECTIVE IN A MOUSE COLITIS MODEL
|
Hall, Caroline |
|
|
164 |
4S |
p. S59 |
artikel |
32 |
CURCUMIN-QINGDAI COMBINATION FOR PATIENTS WITH ACTIVE ULCERATIVE COLITIS: A RANDOMIZED DOUBLE-BLINDED PLACEBO-CONTROLLED CLINICAL TRIAL
|
Ben-Horin, Shomron |
|
|
164 |
4S |
p. S12-S13 |
artikel |
33 |
DEFINING LONG-TERM QUALITY OF LIFE AND FUNCTIONAL OUTCOMES AFTER REDO ILEAL POUCH ANAL ANASTOMOSIS: WHAT SHOULD PATIENTS AND PROVIDERS EXPECT?
|
Maspero, Marianna |
|
|
164 |
4S |
p. S86 |
artikel |
34 |
DELAYED ONSET OF TREATMENT IN A PATIENT WITH ULCERATIVE COLITIS: A CASE OF HOW DISPARITIES AFFECT HEALTHCARE ACCESS
|
Ibarra, Maria |
|
|
164 |
4S |
p. S53-S54 |
artikel |
35 |
DEMOCRATIC DELIBERATION TO ASSESS VETERAN PREFERENCES FOR BIOSIMILAR MEDICATION SWITCHING FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE IN A RESOURCE CONSCIOUS SETTING
|
Ryan, Kerry |
|
|
164 |
4S |
p. S51-S52 |
artikel |
36 |
DEVELOPMENT AND VALIDATION OF A PATIENT-REPORTED OUTCOME MEASURE FOR CROHN’S DISEASE: THE CROHN’S DISEASE-HEALTH INDEX (CD-HI), A FULLY VALIDATED TOOL TO BOLSTER CLINICAL TRIAL AND RESEARCH INFRASTRUCTURE
|
Rosero, Spencer |
|
|
164 |
4S |
p. S94-S95 |
artikel |
37 |
DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAÏVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS
|
Dhaliwal, Jasbir |
|
|
164 |
4S |
p. S72-S73 |
artikel |
38 |
DEVELOPMENT OF A NOVEL DRUG DELIVERY SYSTEM (DDS) TO DELIVER DRUGS DIRECTLY TO THE COLONIC MUCOSA TO IMPROVE EFFICACY AND REDUCE SYSTEMIC EXPOSURE FOR THE TREATMENT OF ULCERATIVE COLITIS (UC)
|
Lee, Shaoying Nikki |
|
|
164 |
4S |
p. S13 |
artikel |
39 |
DEVELOPMENT OF NANOPARTICLE-ENCAPSULATED BRD4 INHIBITORS FOR NOVEL EPIGENETIC THERAPEUTICS OF IBD
|
Shah, Mansi |
|
|
164 |
4S |
p. S5-S6 |
artikel |
40 |
DIFFERENTIAL ABUNDANCE OF THE FUNGAL MYCOBIOME IN PATIENTS WITH ULCERATIVE COLITIS
|
Hsia, Katie |
|
|
164 |
4S |
p. S63-S64 |
artikel |
41 |
DO PROVIDERS FAIL TO RECOGNIZE ANXIETY IN SOCIALLY VULNERABLE PATIENTS WITH INFLAMMATORY BOWEL DISEASE?
|
Sheehan, Jessica |
|
|
164 |
4S |
p. S54 |
artikel |
42 |
DRUG INTERACTION BETWEEN PAXLOVID AND TACROLIMUS IN AN ADOLESCENT WITH INFLAMMATORY BOWEL DISEASE
|
Zaarur, Leenoy |
|
|
164 |
4S |
p. S15 |
artikel |
43 |
EFFECTS OF ACTIVE PATIENT PARTICIPATION IN AN INFLAMMATORY BOWEL DISEASE QUALITY IMPROVEMENT PROGRAM ON HEALTHCARE UTILIZATION OUTCOMES
|
Dang, Nhu |
|
|
164 |
4S |
p. S67-S68 |
artikel |
44 |
EFFICACY AND SAFETY OF HYPERBARIC OXYGEN THERAPY IN FISTULIZING CROHN’S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
Dokmak, Amr |
|
|
164 |
4S |
p. S81 |
artikel |
45 |
EFFICACY AND SAFETY OF VEDOLIZUMAB AND TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF STEROID-REFRACTORY MICROSCOPIC COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
Chehade, Nabil El Hage |
|
|
164 |
4S |
p. S9-S10 |
artikel |
46 |
EFFICACY OF UPADACITINIB IN PATIENTS PREVIOUSLY TREATED WITH TOFACITINIB FOR THE MANAGEMENT OF ULCERATIVE COLITIS
|
Radcliffe, Marlana |
|
|
164 |
4S |
p. S104-S105 |
artikel |
47 |
EFFICIENCY OF DUAL THERAPY WITH VEDOLIZUMAB AND TOFACITINIB IN REFRACTORY ULCERATIVE COLITIS PATIENTS – SINGLE CENTRE EXPERIENCE
|
Kolar, Martin |
|
|
164 |
4S |
p. S100 |
artikel |
48 |
EICOSATETRAYNOIC ACID REGULATES PRO-FIBROTIC PATHWAYS IN AN INDUCED PLURIPOTENT STEM CELL DERIVED MACROPHAGE:HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE
|
Dreskin, Benjamin |
|
|
164 |
4S |
p. S97-S98 |
artikel |
49 |
ENDOSCOPIC SCORE INTER-READER CONCORDANCE ANALYSIS FROM A PHASE 2B STUDY IN PATIENTS WITH MILD-TO-MODERATE UC
|
Feagan, Brian |
|
|
164 |
4S |
p. S23-S24 |
artikel |
50 |
ENGAGING PATIENTS IN INFLAMMATORY BOWEL DISEASE CARE — WHAT DETERMINES ACTIVE PARTICIPATION?
|
Dang, Nhu |
|
|
164 |
4S |
p. S81-S82 |
artikel |
51 |
EPITHELIAL CELLS OF ULCERATIVE COLITIS PATIENTS REQUIRE NORMAL LEVELS OF MITOCHONDRIA AND BETA-CATENIN TO UTILIZE BUTYRATE METABOLISM AND PROMOTE ULCER HEALING
|
Erinkitola, Iyabo |
|
|
164 |
4S |
p. S59-S60 |
artikel |
52 |
ERGOGENIC AID USE IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE AND MEDICAL PROFESSIONAL COMFORTABILITY IN NUTRITIONAL EDUCATION
|
Diefendorf, Caitlin |
|
|
164 |
4S |
p. S20-S21 |
artikel |
53 |
ERYTHEMA NODOSUM AND PYODERMA GANGRENOSUM IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
|
Yousif, Miranda |
|
|
164 |
4S |
p. S77-S78 |
artikel |
54 |
ESRD IN PATIENTS WITH IBD: AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2015-2019
|
Chhoun, Christopher |
|
|
164 |
4S |
p. S93 |
artikel |
55 |
ESTABLISHMENT AND TREATMENT OF MURINE COLONOIDS TO STUDY THE EPITHELIAL EFFECTS OF INTESTINAL INFLAMMATION IN VITRO
|
Crawford, Erin |
|
|
164 |
4S |
p. S98-S99 |
artikel |
56 |
EVALUATION OF CLINICAL VARIABLES, RADIOLOGICAL VISUAL ANALOG SCORING, AND RADIOMICS FEATURES ON CT ENTEROGRAPHY FOR CHARACTERIZING SEVERE INFLAMMATION AND FIBROSIS IN STRICTURING CROHN’S DISEASE
|
Sleiman, Joseph |
|
|
164 |
4S |
p. S16-S17 |
artikel |
57 |
EXCESS DIETARY SUGAR ALTERS COLONOCYTE METABOLISM AND IMPAIRS THE EARLY PROLIFERATIVE RESPONSE TO DAMAGE
|
Burr, Ansen |
|
|
164 |
4S |
p. S60 |
artikel |
58 |
EXPLORING RELATEDNESS AS SOUGHT BY ADOLESCENTS AND YOUNG ADULTS IN AN ONLINE INSTAGRAM INFLAMMATORY BOWEL DISEASE SUPPORT COMMUNITY
|
Malloy, Caeli |
|
|
164 |
4S |
p. S86-S87 |
artikel |
59 |
FEASIBILITY OF A NURSE AND DIETITIAN-LED IBD SURGICAL PREHABILITATION PROGRAM
|
Banty, Andrea |
|
|
164 |
4S |
p. S21 |
artikel |
60 |
FOOD ACCESS AND MENTAL HEALTH IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
|
Zeky, Nicole |
|
|
164 |
4S |
p. S21-S22 |
artikel |
61 |
FUNCTIONAL DISABILITY INVENTORY AND ASSOCIATIONS WITH RACE, ETHNICITY, INCOME AND FOOD INSECURITY
|
Zeky, Nicole |
|
|
164 |
4S |
p. S54-S55 |
artikel |
62 |
GROWTH OUTCOMES OF IV ANTI-TNF BIOSIMILARS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
|
McClinchie, Madeline |
|
|
164 |
4S |
p. S78 |
artikel |
63 |
GUT-BIOME MODULATION WITH HUMAN MILK OLIGOSACCHARIDE (HMO) BASED SYNBIOTIC FOR A COMPLETE AND DEEP REMISSION IN CROHN’S DISEASE: A CASE STUDY
|
Tummala, Sai |
|
|
164 |
4S |
p. S101 |
artikel |
64 |
GUT MICROBIAL METABOLISM OF 5-ASA IS PROSPECTIVELY ASSOCIATED WITH TREATMENT FAILURE IN PATIENTS WITH IBD
|
Mehta, Raaj |
|
|
164 |
4S |
p. S73-S74 |
artikel |
65 |
HISTOPATHOLOGICAL CHARACTERIZATION OF A CHRONIC DSS-INDUCED MOUSE MODEL OF IBD WITH INTESTINAL FIBROSIS
|
Nielsen, Malte Hasle |
|
|
164 |
4S |
p. S6 |
artikel |
66 |
HLA-DQA1*05 ASSOCIATES WITH IMMUNOGENICITY AND LOSS OF RESPONSE TO ANTI-TNF THERAPY IN THE IBD POPULATION: A META-ANALYSIS
|
Bergstein, Suzannah |
|
|
164 |
4S |
p. S74 |
artikel |
67 |
HOSPITALIZATION TRENDS IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH POUCHITIS: A POPULATION-BASED STUDY
|
Nawaz, Ahmad |
|
|
164 |
4S |
p. S44 |
artikel |
68 |
IBD AND RHEUMATOLOGICAL DISEASE OVERLAP IN A PREDOMINATELY AFRICAN AMERICAN CLINIC POPULATION AS COMPARED TO A NATIONAL INPATIENT DATABASE
|
Almujarkesh, Mohamad Khaled |
|
|
164 |
4S |
p. S45 |
artikel |
69 |
ILEOSTOMY AND RISK OF ACUTE KIDNEY INJURY IN PATIENTS WITH CROHN'S DISEASE
|
Abomhya, Ahmed |
|
|
164 |
4S |
p. S30-S31 |
artikel |
70 |
IMPACT OF NON ST- ELEVATION MYOCARDIAL INFARCTION (NSTEMI) ON PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Suga, Herman |
|
|
164 |
4S |
p. S82-S83 |
artikel |
71 |
IMPROVEMENT IN BOWEL URGENCY IS ASSOCIATED WITH STOOL FREQUENCY AND RECTAL BLEEDING REMISSION AT 12 AND 52 WEEKS IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS
|
Long, Millie |
|
|
164 |
4S |
p. S13-S14 |
artikel |
72 |
INCIDENTAL DYSPLASIA DURING TOTAL PROCTOCOLECTOMY WITH ILEOANAL POUCH: IS IT ASSOCIATED WITH WORSE OUTCOMES?
|
Maspero, Marianna |
|
|
164 |
4S |
p. S31 |
artikel |
73 |
INCORPORATION OF RISK ASSESSMENT TOOL IMPACTS PATIENT AND GASTROENTEROLOGIST CONFIDENCE AND TREATMENT DECISION MAKING IN BIONAIVE CROHN’S DISEASE
|
Ungaro, Ryan |
|
|
164 |
4S |
p. S31-S32 |
artikel |
74 |
INFLAMMATORY BOWEL DISEASE AND ASSOCIATED CARDIOVASCULAR DISEASE OUTCOMES: A SYSTEMATIC REVIEW
|
Naz, Sidra |
|
|
164 |
4S |
p. S32 |
artikel |
75 |
INNATE TL1A SIGNALING PROMOTES INTESTINAL NEUTROPHIL ACTIVATION AND COLITIS ASSOCIATED CANCER
|
Pires, Silvia |
|
|
164 |
4S |
p. S64-S65 |
artikel |
76 |
INTESTINAL PERFORATIONS IN PATIENTS WITH IBD: AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2015-2019
|
Chhoun, Christopher |
|
|
164 |
4S |
p. S93-S94 |
artikel |
77 |
INVESTIGATING THE USE OF THE SOCIAL VULNERABILITY INDEX TO PREDICT HEALTHCARE UTILIZATION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Dang, Nhu |
|
|
164 |
4S |
p. S55 |
artikel |
78 |
IRE1α-XBP1 CONTROLS GROUP 3 INNATE LYMPHOID CELLS IN INFLAMMATORY BOWEL DISEASE
|
Cao, Siyan |
|
|
164 |
4S |
p. S65-S66 |
artikel |
79 |
LMT503, A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE THROUGH MACROPHAGE POLARIZATIONS BY METABOLIC REPROGRAMMING OF ACTIVATED MACROPHAGE
|
Lee, Wheeseong |
|
|
164 |
4S |
p. S6-S7 |
artikel |
80 |
LONGITUDINAL COMPRESSION THERAPY FOR SMALL BOWEL STRICTURE CROHN’S DISEASE: DURABLE RESOLUTION IN SWINE MODEL
|
Verde, Juan |
|
|
164 |
4S |
p. S7 |
artikel |
81 |
LONGITUDINAL MONITORING OF INFLAMMATORY BOWEL DISEASE ACTIVITY USING WEARABLE DEVICES THROUGH INFLAMMATORY MARKERS IN SWEAT
|
Hirten, Robert |
|
|
164 |
4S |
p. S24-S25 |
artikel |
82 |
LONG RECTAL CUFF SYNDROME AFTER ILEOANAL POUCH FOR INFLAMMATORY BOWEL DISEASE
|
Maspero, Marianna |
|
|
164 |
4S |
p. S32-S33 |
artikel |
83 |
LOSS OF EPITHELIAL DUOX2 SIGNALING IS ACCOMPANIED BY A REDUCTION IN AKKERMANSIACEAE AND PROMOTES THE DEVELOPMENT OF METABOLIC SYNDROME IN A MICROBIOME-DEPENDENT MANNER
|
Hazime, Hajar |
|
|
164 |
4S |
p. S91-S92 |
artikel |
84 |
MACHINE LEARNING-BASED PREDICTION OF GEBOES SCORE AND HISTOLOGIC IMPROVEMENT AND REMISSION THRESHOLDS IN ULCERATIVE COLITIS
|
Shanis, Zahil |
|
|
164 |
4S |
p. S25-S26 |
artikel |
85 |
MANAGEMENT STRATEGIES FOR OBESITY VARY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Dave, Sonya |
|
|
164 |
4S |
p. S83-S84 |
artikel |
86 |
METABOLOMICS ANALYSIS IDENTIFIED AN ORALLY ACTIVE METABOLITE FOR TREATING CROHN’S DISEASE-ASSOCIATED INTESTINAL FIBROSIS
|
Koon, Hon Wai |
|
|
164 |
4S |
p. S60-S61 |
artikel |
87 |
METHODS TO DERIVE A CROHN’S DISEASE ACTIVITY INDEX FROM ELECTRONIC HEALTH RECORDS DATA
|
Swenson, Anna |
|
|
164 |
4S |
p. S26-S27 |
artikel |
88 |
METHODS TO DERIVE A MODIFIED MAYO SCORE FROM ELECTRONIC HEALTH RECORDS DATA
|
Swenson, Anna |
|
|
164 |
4S |
p. S27 |
artikel |
89 |
MOOD DISORDERS AND OUTCOMES OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A 2016-2019 NATIONWIDE ANALYSIS
|
Kilani, Yassine |
|
|
164 |
4S |
p. S33-S34 |
artikel |
90 |
MORTALITY AND MORBIDITY DIFFERENCE IN GERIATRICS PATIENTS HOSPITALIZED FOR INFLAMMATORY BOWEL DISEASE: POPULATION-BASED AGE-STRATIFIED RETROSPECTIVE STUDY
|
Aldiabat, Mohammad |
|
|
164 |
4S |
p. S34-S35 |
artikel |
91 |
MUCOSAL EXPRESSION OF GENES PI3, ANXA1, AND VDR DESCRIMINATES CROHNS DISEASE FROM ULCERATIVE COLITIS IN INFLAMMATORY BOWEL DISEASE PATIENTS
|
James, Jaslin |
|
|
164 |
4S |
p. S17 |
artikel |
92 |
MUCOSAL IMMUNE SIGNATURES OF PERIANAL FISTULIZING CROHN’S DISEASE BY MASS CYTOMETRY
|
Cao, Siyan |
|
|
164 |
4S |
p. S74-S75 |
artikel |
93 |
MULTIDISCIPLINARY MANAGEMENT, ANTI-TNF THERAPY, AND CLINICAL OUTCOMES OF INTERNALLY PENETRATING CROHN’S DISEASE COMPLICATION IN PEDIATRICS: INTERIM ANALYSES OF A MULTICENTER RETROSPECTIVE COHORT
|
Constant, Brad |
|
|
164 |
4S |
p. S10-S11 |
artikel |
94 |
MULTIPLE ENVIRONMENTAL AND SOCIAL DETERMINANTS OF HEALTH FACTORS WERE NOT ASSOCIATED WITH THE GASTROINTESTINAL SYMPTOMATIC BURDEN OF ULCERATIVE COLITIS WITH MUCOSAL HEALING
|
Tse, Chung Sang |
|
|
164 |
4S |
p. S56 |
artikel |
95 |
NAD+ DEPLETION IN THE INTESTINAL EPITHELIUM RESULTS IN MITOCHONDRIAL DYSFUNCTION AND INFLUENCES THE PATHOGENESIS OF EXPERIMENTAL COLITIS
|
Novak, Elizabeth |
|
|
164 |
4S |
p. S8 |
artikel |
96 |
NEW ONSET OF INFLAMMATORY BOWEL DISEASE IN A PATIENT WITH EOSINOPHILIC ESOPHAGITIS: 10-YEAR CONSTELLATION OF AUTOIMMUNE GASTROINTESTINAL DISORDERS
|
Guzman, Adalberto |
|
|
164 |
4S |
p. S68-S69 |
artikel |
97 |
NON-MEDICAL SWITCHING FROM INFLIXIMAB TO A BIOSIMILAR IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE
|
McNicol, Megan |
|
|
164 |
4S |
p. S79 |
artikel |
98 |
OUTCOMES OF PEPTIC ULCER DISEASE IN PATIENTS WITH CROHN’S DISEASE: A FOUR YEAR NATIONWIDE ANALYSIS
|
Kilani, Yassine |
|
|
164 |
4S |
p. S35-S36 |
artikel |
99 |
PATHOPHYSIOLOGY OF IRRITABLE BOWEL SYNDROME IN PATIENTS WITH QUIESCENT INFLAMMATORY BOWEL DISEASE
|
Oliveira, Diego Brandão |
|
|
164 |
4S |
p. S92 |
artikel |
100 |
PATIENT PERSPECTIVE OF BOWEL URGENCY AND BOWEL URGENCY-RELATED ACCIDENTS IN CROHN’S DISEASE
|
Jairath, Vipul |
|
|
164 |
4S |
p. S87 |
artikel |
101 |
PATIENT PERSPECTIVES OF BOWEL URGENCY AND BOWEL URGENCY-RELATED ACCIDENTS IN ULCERATIVE COLITIS
|
Jairath, Vipul |
|
|
164 |
4S |
p. S87-S88 |
artikel |
102 |
PATTERNS OF STEROID USE AMONG A REAL-WORLD NATIONAL COHORT OF VETERANS WITH INFLAMMATORY BOWEL DISEASE
|
Pham, Codey |
|
|
164 |
4S |
p. S101-S102 |
artikel |
103 |
PENTOSAN POLYSULFATE-ASSOCIATED DYSPLASIA IN INFLAMMATORY BOWEL DISEASE: A CASE SERIES
|
Anderson, Jenna |
|
|
164 |
4S |
p. S36 |
artikel |
104 |
PERIPHERAL BLOOD EXTRACELLULAR VESICLE LIPIDS AS BIOMARKERS FOR HUMAN INFLAMMATORY BOWEL DISEASE
|
Hassan, Syed Adeel |
|
|
164 |
4S |
p. S17-S18 |
artikel |
105 |
PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-EXPERIENCED PATIENTS WITH CROHN’S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
|
Zhdanava, Maryia |
|
|
164 |
4S |
p. S45-S46 |
artikel |
106 |
PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF AMISELIMOD, A SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 STUDY
|
Lee, Jimin |
|
|
164 |
4S |
p. S96 |
artikel |
107 |
PHYSIOLOGICAL METRICS COLLECTED FROM WEARABLE DEVICES IDENTIFY INFLAMMATORY AND CLINICAL INFLAMMATORY BOWEL DISEASE FLARES
|
Hirten, Robert |
|
|
164 |
4S |
p. S28 |
artikel |
108 |
POTENTIAL EFFECTS OF FOOD ON A NOVEL DRUG DELIVERY SYSTEM (DDS) TO DELIVER A THERAPEUTIC COMPOUND IN THE COLON
|
Lee, Shaoying Nikki |
|
|
164 |
4S |
p. S14-S15 |
artikel |
109 |
PREDICTORS OF DEVELOPING MULTIPLE EXTRA-INTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE
|
Alizadeh, Madeline |
|
|
164 |
4S |
p. S36-S37 |
artikel |
110 |
PRELIMINARY EVIDENCE FOR A RELATIONSHIP BETWEEN HEART RATE VARIABILITY AND FATIGUE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
|
McGarva, Josie |
|
|
164 |
4S |
p. S88 |
artikel |
111 |
PRIMARY EOSINOPHILIC COLITIS WITH CONCOMITANT NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASE – A DIAGNOSITIC CONUNDRUM
|
Miranda, Clive |
|
|
164 |
4S |
p. S105-S106 |
artikel |
112 |
PRIMARY SCLEROSING CHOLANGITIS AND AUTOIMMUNE HEPATITIS: OVERLAPPING CHALLENGES IN DIAGNOSIS AND TREATMENT
|
Fiske, Hannah |
|
|
164 |
4S |
p. S37-S38 |
artikel |
113 |
PROBIOTIC BIFIDOBACTERIUM AND A NEW GENERATION POSTBIOTIC: ALGINIC ACID
|
Bozkurt, Hüseyin |
|
|
164 |
4S |
p. S61 |
artikel |
114 |
PRO-INFLAMMATORY SIRPα-EXPRESSING MONOCYTES AND MACROPHAGES MEDIATE ANTI-TNF REFRACTORY CROHN'S DISEASE IN CHILDREN
|
Geem, Duke |
|
|
164 |
4S |
p. S76 |
artikel |
115 |
QINGDAI (QD) FOR PATIENTS WITH ACTIVE ULCERATIVE COLITIS: A RETROSPECTIVE ISRAELI NATIONAL EXPERIENCE
|
Kopylov, Uri |
|
|
164 |
4S |
p. S106-S107 |
artikel |
116 |
QUANTITATIVE AND EXPLAINABLE ARTIFICIAL INTELLIGENCE (AI)-POWERED APPROACHES TO PREDICT ULCERATIVE COLITIS DISEASE ACTIVITY FROM HEMATOXYLIN AND EOSIN (H&E)-STAINED WHOLE SLIDE IMAGES (WSI)
|
Sucipto, Kathleen |
|
|
164 |
4S |
p. S28-S29 |
artikel |
117 |
REAL-WORLD EXPERIENCE FOR BIOLOGIC USE IN IBD IN THAI: A SINGLE-CENTER EXPERIENCE
|
Limsrivilai, Julajak |
|
|
164 |
4S |
p. S69 |
artikel |
118 |
REAL-WORLD EXPERIENCE WITH TOFACITINIB DOSE DE-ESCALATION IN PATIENTS WITH MODERATE AND SEVERE ULCERATIVE COLITIS
|
Yu, Amy |
|
|
164 |
4S |
p. S102 |
artikel |
119 |
REAL WORLD IMPLEMENTATION OF TREAT-TO-TARGET IN PATIENTS WITH IBD IN A LEARNING HEALTH SYSTEM: AN IBD QORUS COLLABORATIVE STUDY
|
Singh, Siddharth |
|
|
164 |
4S |
p. S52-S53 |
artikel |
120 |
REAL-WORLD USTEKINUMAB PERSISTENCE IN PATIENTS WITH ULCERATIVE COLITIS ATTAINING THE MAINTENANCE PHASE
|
Zhdanava, Maryia |
|
|
164 |
4S |
p. S46-S47 |
artikel |
121 |
REPOGRAMING OF THE INTESTINAL IMMUNE CELL COMPARTMENT DEFINES THE RESPONSE TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN CROHNS DISEASE
|
Guisado, Daniela |
|
|
164 |
4S |
p. S66-S67 |
artikel |
122 |
SAFETY AND EFFICACY OF MYCOPHENOLATE MOFETIL TREATMENT FOR REFRACTORY CROHN’S DISEASE
|
Rosenfeld, Sam |
|
|
164 |
4S |
p. S107 |
artikel |
123 |
SAFETY OF PERIOPERATIVE BIOLOGICS IN PATIENTS WITH IBD UNDERGOING RESECTIVE BOWEL SURGERY: THE MUNICH IBD CENTER EXPERIENCE
|
Ochsenkühn, Thomas |
|
|
164 |
4S |
p. S2-S3 |
artikel |
124 |
SELECTION OF DIETARY FIBERS FOR GUT HEALTH BASED ON THEIR PHYSICOCHEMICAL PROPERTIES
|
Moncada, Edward |
|
|
164 |
4S |
p. S61-S62 |
artikel |
125 |
SEPSIS IN THE SETTINGS OF INFLAMMATORY BOWEL DISEASE: STUDYING THE OUTCOMES OF OVER EIGHT-MILLION PATIENTS
|
Aldiabat, Mohammad |
|
|
164 |
4S |
p. S38-S39 |
artikel |
126 |
SEX-BASED DIFFERENCES IN DRUG DURABILITY AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES
|
Tirath, Ankita |
|
|
164 |
4S |
p. S96-S97 |
artikel |
127 |
SINGLE CELL RNA SEQUENCING OF ULCERATIVE COLITIS AND CROHN'S DISEASE TISSUE SAMPLES INFORMS THE SELECTION OF TREM1 AS A TARGET FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
|
Grant, Sarah |
|
|
164 |
4S |
p. S67 |
artikel |
128 |
SINGLE CENTER EXPERIENCE WITH UPADACITINIB FOR REFRACTORY PEDIATRIC INFLAMMATORY BOWEL DISEASE
|
Bergstein, Suzannah |
|
|
164 |
4S |
p. S79 |
artikel |
129 |
SMOKING IS NOT AN INDEPENDENT RISK FACTOR FOR SURGERY IN PATIENTS WITH CROHN'S DISEASE ON BIOLOGIC THERAPY
|
Shmais, Manar |
|
|
164 |
4S |
p. S39 |
artikel |
130 |
SOCIALLY VULNERABLE PATIENTS WITH INFLAMMATORY BOWEL DISEASE ARE AT INCREASED RISK FOR VACCINE PREVENTABLE ILLNESS
|
Jordan, Ariel |
|
|
164 |
4S |
p. S56-S57 |
artikel |
131 |
SPATIAL CONCORDANCE OF LEFT AND RIGHT COLON FINDINGS IN PEDIATRIC PATIENTS WITH ULCERATIVE COLITIS AFTER TREAMTENT
|
Thadasina, Meenal |
|
|
164 |
4S |
p. S80 |
artikel |
132 |
STRUCTURAL MODIFICATIONS OF BUTYRATE REVEAL TEMPLATES FOR INTESTINAL EPITHELIAL HIF STABILIZERS
|
Ornelas, Alfredo |
|
|
164 |
4S |
p. S62 |
artikel |
133 |
SUBCUTANEOUS INFLIXIMAB IN REFRACTORY CROHN’S DISEASE PATIENTS AFTER THE MULTIPLE TREATMENT FAILURES - SHORT TREATMENT OUTCOMES
|
Lukas, Milan |
|
|
164 |
4S |
p. S97 |
artikel |
134 |
SUPERIOR PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-NAÏVE PATIENTS WITH CROHN’S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
|
Zhdanava, Maryia |
|
|
164 |
4S |
p. S47 |
artikel |
135 |
THE BENEFICIAL ROLE OF PROBIOTIC AKKERMANSIA MUCINIPHILA IN INFLAMMATORY BOWEL DISEASE
|
Zheng, Mengyu |
|
|
164 |
4S |
p. S92 |
artikel |
136 |
THE EFFECT OF VEDOLIZUMAB ON CD8 T CELL REPERTOIRE HOMOGENEITY AND BLOOD-GUT TRAFFICKING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Williams, Kyle |
|
|
164 |
4S |
p. S103 |
artikel |
137 |
THE EFFECTS OF BIOLOGIC AND SMALL MOLECULE INHIBITOR THERAPY ON THE MUCOSAL IMMUNE SYSTEM IN ULCERATIVE COLITIS
|
Briggs, Kristi |
|
|
164 |
4S |
p. S57 |
artikel |
138 |
THE GUT MICROBIOME REGULATES EFFICACY OF SULFASALAZINE THERAPY FOR SPONDYLOARTHRITIS IN INFLAMMATORY BOWEL DISEASE
|
Lima, Svetlana |
|
|
164 |
4S |
p. S93 |
artikel |
139 |
THE IMPACT OF INFLAMMATORY BOWEL DISEASES ON THE OUTCOMES OF PATIENTS ADMITTED WITH ACUTE VIRAL HEPATITIS: A 2016-2019 NATIONWIDE ANALYSIS
|
Kilani, Yassine |
|
|
164 |
4S |
p. S39-S40 |
artikel |
140 |
THE INTERPLAY OF IBD AND DEPRESSION IN INPATIENT LENGTH OF STAY, COST, AND COMPLICATIONS
|
Dong, Rachel |
|
|
164 |
4S |
p. S88-S89 |
artikel |
141 |
THE ONSET AND SEVERITY OF ULCERATIVE COLITIS IN IL-10 -/- MICE IS NOT DEPENDENT ON FECAL MICROBIOTA TRANSPLANTATION FROM ULCERATIVE COLITIS PATIENTS
|
Roy, Kayla |
|
|
164 |
4S |
p. S64 |
artikel |
142 |
THE ORAL GLUTMATE CARBOXYPEPTIDASE II INHIBITOR (S)-IBD3540 ROBUSTLY ATTENUATES INFLAMMATION IN SPONTANEOUS IL10 COLITIS
|
Peters, Diane |
|
|
164 |
4S |
p. S8-S9 |
artikel |
143 |
THE PRECIOUS STUDY: A PROSPECTIVE, OBSERVATIONAL STUDY OF CD8+ BIOMARKER BASED PROGNOSTIC TEST IN NORTH AMERICAN IBD PATIENTS
|
Chen, Lea Ann |
|
|
164 |
4S |
p. S76-S77 |
artikel |
144 |
THE PRESENCE OF CARDIAC ARRHYTHMIAS IS ASSOCIATED WITH INCREASED MORTALITY IN HOSPITALIZED PATIENTS WHO ARE UNDERGOING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) WITH A CONCURRENT DIAGNOSIS OF IBD
|
Suga, Herman |
|
|
164 |
4S |
p. S94 |
artikel |
145 |
THE RELATIONSHIP BETWEEN SELF-REPORTED SLEEP, WRIST ACTIGRAPHY, AND SYMPTOMS AMONG ADULTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
|
Winders, Samantha |
|
|
164 |
4S |
p. S89-S90 |
artikel |
146 |
THE UNFORTUNATE PERFECT STORM - SEPTIC SHOCK DUE TO CHRONIC IMMUNOSUPPRESIVE MEDICAL THERAPY AND MEDICATION-INDUCED LYMPHOMA
|
Ravichander, Benjamin |
|
|
164 |
4S |
p. S3 |
artikel |
147 |
THE USE OF IMMUNOMODULATORS, BIOLOGIC THERAPIES AND SMALL MOLECULES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND SOLID ORGAN TRANSPLANTS
|
Ghusn, Wissam |
|
|
164 |
4S |
p. S3-S4 |
artikel |
148 |
THE UTILITY OF BIOPSYING ENDOSCOPICALLY NORMAL APPEARING TERMINAL ILEUM
|
Vora, Haily |
|
|
164 |
4S |
p. S18-S19 |
artikel |
149 |
THIRD TIME’S THE CHARM? INDICATIONS AND LONG-TERM OUTCOMES AFTER REDO-REDO ILEAL POUCH ANAL ANASTOMOSIS
|
Maspero, Marianna |
|
|
164 |
4S |
p. S40-S41 |
artikel |
150 |
TRANSFER RNA MODIFICATION CONTRIBUTE TO PATHOGENESIS OF INTESTINAL INFLAMMATION BY ALTERING EPITHELIAL BARRIERS
|
Zhang, Jilei |
|
|
164 |
4S |
p. S70-S71 |
artikel |
151 |
TREATMENT PATTERNS OF PEDIATRIC AND ADULT PATIENTS WITH CROHN’S DISEASE
|
Chan, Wai Man |
|
|
164 |
4S |
p. S47-S48 |
artikel |
152 |
TREATMENT PATTERNS OF PEDIATRIC AND ADULT PATIENTS WITH ULCERATIVE COLITIS
|
Chan, Wai Man |
|
|
164 |
4S |
p. S48-S49 |
artikel |
153 |
TREATMENT PREFERENCES IN CROHN’S DISEASE PERIANAL FISTULA: PERSPECTIVES OF HEALTHCARE PROFESSIONALS
|
Jiang, Jeanne |
|
|
164 |
4S |
p. S84-S85 |
artikel |
154 |
TRENDS AND RELATED FACTORS OF QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Kim, Sihyun |
|
|
164 |
4S |
p. S90-S91 |
artikel |
155 |
USE OF UPADACITINIB IN 11 TOFACITINIB-REFRACTORY ULCERATIVE COLITIS PATIENTS AT A SINGLE TERTIARY CARE CENTER
|
Levine, Jake |
|
|
164 |
4S |
p. S103-S104 |
artikel |
156 |
USING A REAL TIME DASHBOARD TO SUPPORT POPULATION HEALTH IN INFLAMMATORY BOWEL DISEASE
|
Lloyd, Robert |
|
|
164 |
4S |
p. S85 |
artikel |
157 |
USING R TO ADVANCE PATIENT-CENTRIC RESEARCH IN THE STUDY OF A PROSPECTIVE ADULT RESEARCH COHORT
|
Fehlmann, Tara |
|
|
164 |
4S |
p. S29 |
artikel |
158 |
VEDOLIZUMAB, USTEKINUMAB AND TOFACITINIB AS TRIPLE THERAPY FOR ULCERATIVE COLITIS
|
Thurston, Theresa |
|
|
164 |
4S |
p. S104 |
artikel |
159 |
WHICH IS IMPORTANT? GLUTEN FREE DIET OR INFLAMMATORY BOWEL DISEASE MEDICATIONS IN SUBJECTS WITH AN OVERLAP WITH CELIAC DISEASE AND INFLAMMATORY BOWEL DISEASE: OBSERVATIONS FROM A CASE SERIES AT A LARGE ACADEMIC CENTER
|
Montrose, Jonathan |
|
|
164 |
4S |
p. S22 |
artikel |
160 |
WHOLE EXOME SEQUENCING OF A MULTIPLEX CROHN’S DISEASE FAMILY IDENTIFIES RARE ALTERATIONS IN PYGB ANDXRN2 AS POTENTIALLY HIGH IMPACT RISK VARIANTS OF DISEASE
|
Chen, Lea Ann |
|
|
164 |
4S |
p. S50-S51 |
artikel |
161 |
YIELD OF SERIAL TESTING FOR TUBERCULOSIS EXPOSURE IN THE STUDY OF A PROSPECTIVE ADULT RESEARCH COHORT WITH INFLAMMATORY BOWEL DISEASES (SPARC IBD)
|
Lapp, Sean |
|
|
164 |
4S |
p. S19-S20 |
artikel |